Effect of clinician information sessions on diagnostic testing for Chagas disease

被引:4
|
作者
West, Helen Mahoney [1 ]
Milliren, Carly E. [2 ]
Manne-Goehler, Jennifer [3 ]
Davis, Jillian [4 ]
Gallegos, Jaime [4 ]
Perez, Juan Huanuco [4 ]
Koehler, Julia R. [1 ,5 ]
机构
[1] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA
[3] Massachusetts Gen Brigham Hosp, Boston, MA USA
[4] East Boston Neighborhood Hlth Ctr, Boston, MA USA
[5] Harvard Med Sch, Dept Pediat, Boston, MA USA
来源
PLOS NEGLECTED TROPICAL DISEASES | 2022年 / 16卷 / 06期
关键词
UNITED-STATES; CUSTOMS ENFORCEMENT; SYSTEMIC RACISM; HEALTH; IMPACT; IMMIGRATION; MORTALITY; CARE; INCENTIVES; BURDEN;
D O I
10.1371/journal.pntd.0010524
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundChagas disease is a potentially life-threatening neglected disease of poverty that is endemic in continental Latin America. Caused by Trypanosoma cruzi (T. cruzi), it is one of six parasitic diseases in the United States targeted by the Centers for Disease Control as a public health problem in need of action. An estimated 300,000 people are infected with T. cruzi in the United States (US). Although its morbidity, mortality and economic burden are high, awareness of Chagas disease is lacking among many healthcare providers in the US. The purpose of this analysis is to determine if the number of diagnostic tests performed at a community health center serving an at-risk population for Chagas disease increased after information sessions. A secondary aim was to determine if there was a difference by provider type, i.e., nurse practitioner vs. physician, or by specialty in the number of patients screened. Methodology/Principal findingsWe conducted a retrospective data analysis of the number of Chagas serology tests performed at a community health center before and after information sessions for clinicians. A time series analysis was conducted focusing on the Adult and Family Medicine Departments at East Boston Neighborhood Health Center (EBNHC). Across all departments there were 1,957 T. cruzi tests performed before the sessions vs. 2,623 after the sessions. Interrupted time series analysis across departments indicated that testing volume was stable over time prior to the sessions (pre-period slope = +4.1 per month; p = 0.12), followed by an immediate shift after the session (+51.6; p = 0.03), while testing volume remained stable over time after the session (post-period slope = -6.0 per month; p = 0.11). Conclusion/SignificanceIn this study, Chagas testing increased after information sessions. Clinicians who began testing their patients for Chagas disease after learning of the importance of this intervention added an extra, potentially time-consuming task to their already busy workdays without external incentives or recognition. Author summaryChagas disease is a potentially fatal neglected disease of poverty. It is endemic in continental Latin America with an estimated 300,000 cases in the United States, primarily among low-income people who have immigrated to the US from Latin America. Few Chagas screening programs have been established in the US. Existing recommendations for Chagas disease testing and treatment are rarely followed for many reasons including a paucity of knowledge among providers. We aimed to determine if the number of Chagas tests performed increased after information sessions at a community health center. A secondary aim was to determine if there was a difference in number of tests performed by provider type. We found that the number of T. cruzi serologies performed in the ten months after information sessions increased significantly over that in the ten preceding months. Chagas testing increased across departments, though Chagas diagnostics were an extra and unmitigated time burden on clinicians. Increasing provider knowledge is a major step to increase diagnosis and treatment of this neglected disease, when clinicians are motivated by their inherent prosocial preferences including altruism i.e., by the positive impact of their work on patients' lives.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Definition of a diagnostic routine in individuals with inconclusive serology for chagas disease
    Modolo Picka, Mariele Cristina
    Meira, Domingos Alves
    de Carvalho, Thais Batista
    Peresi, Eliana
    Marcondes-Machado, Jussara
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (02): : 226 - 233
  • [32] STANDARDIZATION OF LABORATORY DIAGNOSTIC RULES FROM THE CHAGAS'S DISEASE
    Dario, Gonzalez
    Mehudy, Medina
    Marco, P.
    Marruffo, M.
    Mary, Eva
    Jesus, Rodriguez
    Querales
    COMUNIDAD Y SALUD, 2005, 3 (02) : 21 - 27
  • [33] COMPARATIVE DIAGNOSTIC SENSITIVITY OF MICROHEMATOCRIT AND XENODIAGNOSIS FOR CHAGAS-DISEASE
    CAMPO, E
    DEHERRERA, FP
    BOCANERA, B
    CASAJUS, M
    ARREDES, H
    QUIPILDOR, D
    BASOMBRIO, MA
    MEDICINA-BUENOS AIRES, 1985, 45 (04) : 394 - 394
  • [34] Update of the state of knowledge on diagnostic techniques of Leishmaniasis and Chagas disease
    Pineda-Rios, Julian
    Gonzalez-Rete, Berenice
    Caneda-Guzman, Isabel Cristina
    Rodriguez-Moreno, Angel
    Sanchez-Cordero, Victor
    Becker, Ingeborg
    Salazar-Schettino, Paz Maria
    REVISTA MEXICANA DE BIODIVERSIDAD, 2024, 95
  • [35] A Systematic Review of High Quality Diagnostic Tests for Chagas Disease
    Afonso, Anna M.
    Ebell, Mark H.
    Tarleton, Rick L.
    PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (11):
  • [36] Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps
    Balouz, V.
    Aguero, F.
    Buscaglia, C. A.
    ADVANCES IN PARASITOLOGY, VOL 97, 2017, 97 : 1 - 45
  • [37] Diagnostic testing for Legionnaires’ disease
    David M. Pierre
    Julianne Baron
    Victor L. Yu
    Janet E. Stout
    Annals of Clinical Microbiology and Antimicrobials, 16
  • [38] Diagnostic testing for Legionnaires' disease
    Pierre, David M.
    Baron, Julianne
    Yu, Victor L.
    Stout, Janet E.
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2017, 16
  • [39] Diagnostic Testing for Lyme Disease
    Kobayashi, Takaaki
    Auwaerter, Paul G.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2022, 36 (03) : 605 - 620